作者
Özcan Başaran, Volkan Dogan, Murat Biteker, Fatma Özpamuk Karadeniz, Ahmet İlker Tekkesin, Yasin Çakıllı, Ceyhan Türkkan, Mehmet Hamidi, Vahit Demir, Mustafa Ozan Gürsoy, Müjgan Tek Öztürk, Gökhan Aksan, Sabri Seyis, Mehmet Ballı, Mehmet Hayri Alıcı, Serdar Bozyel, Cevat Kırma, Osman Beton, Mehmet Tekinalp, Ahmet Çağrı Aykan, Ezgi Kalaycıoğlu, Ismail Bolat, Onur Taşar, Özgen Şafak, Macit Kalçık, Mehmet Yaman, Sinan İnci, Bernas Altıntaş, Sedat Kalkan, Feyza Çalık, Oğuz Karaca, Füsun Helvacı, Kadriye Akay, Yiğit Çanga, Savaş Çelebi, Emine Altuntas, Mehmet Aytürk, Hacı Murat Güneş, Tahir Bezgin, Aytekin Aksakal, Beytullah Çakal, Ayşe Çolak, Özgür Kaplan, Adem Tatlısu, Gökhan Gözübüyük, Selami Demirelli, Adnan Kaya, İbrahim Rencüzoğulları, Zübeyde Bayram, Zeki Şimşek, Murat Civan, Ulaankhu Batgharel, Ali Ekber Ata, Gökhan Göl, Gurbet Özge Mert, Kadir Ugur Mert, Aleks Değirmencioğlu, Özkan Candan, Özlem Özcan Çelebi, Cem Doğan, Fethi Yavuz, Şeref Ulucan, Arif Arısoy, Bingül Dilekçi Şahin, Emrah Ermiş, Serkan Gökaslan, İdris Pektaş, Aslı Tanındı, Kamuran Tekin, Kadriye Memic Sancar, Edip Güvenç Çekiç, Nesrin Filiz Başaran, İbrahim Altun
发表日期
2017/5/1
期刊
European journal of internal medicine
卷号
40
页码范围
50-55
出版商
Elsevier
简介
Objective
No studies have been conducted in Turkey to compare the quality of stroke prevention therapies provided in different healthcare settings in patients with atrial fibrillation (AF). Therefore, we aimed to evaluate possible differences between secondary (SH) and tertiary hospital (TH) settings in the effectiveness of implementing AF treatment strategies.
Methods
Baseline characteristics of 6273 patients with non-valvular AF enrolled in the RAMSES (ReAl-life Multicentre Survey Evaluating Stroke Prevention Strategies in Turkey) study were compared.
Results
Of the study population, 3312 (52.8%) patients were treated in THs and 2961 (47.2%) patients were treated in SHs. Patients treated in the SH setting were older (70.8 ± 9.8 vs. 68.7 ± 11.4 years, p < 0.001), had a lower socioeconomic status, had a higher CHA2DS2VASc and HASBLED scores (3.4 ± 1.4 vs. 3.1 ± 1.7, p < 0.001 and 1.7 ± 1.0 vs. 1.6 ± 1.1, p < 0 …
学术搜索中的文章
Ö Başaran, V Dogan, M Biteker, FÖ Karadeniz… - European journal of internal medicine, 2017